文献速递颈动脉与弓上血管

多学科团队模式改善颈动脉体瘤治疗结局

Improving Outcomes in Carotid Body Tumors Treatment: The Impact of a Multidisciplinary Team Approach.
PubMed 文献 · Ann Vasc Surg · 2021-02-05

结果示B组手术时间、出血量及颈动脉重建需求均低于A组,SDH突变者复发率更高且遗传评估可发现无症状新发肿块。

要点

  • 多学科模式可缩短颈动脉体瘤手术时间并减少出血量。
  • 肿瘤超过45 mm时采用术前辅助腔内操作可进一步减少出血。
  • SDH基因突变患者术后复发风险显著更高,需加强随访。

核心结论

  • 手术切除仍是颈动脉体瘤治疗的金标准,多学科团队模式可改善围手术期结局。
  • 在选定病例中使用术前辅助腔内操作可减少手术时间、出血量及颈动脉重建需求。
  • 遗传咨询与SDH基因分析有助于在无症状患者中发现新发无症状肿块。

研究设计与样本

  • A组为1995—2003年10例(多学科模式建立前),B组为2004—2019年47例(建立后)。
  • A组回顾性评估SDH突变,B组前瞻性评估;术前辅助腔内操作仅在B组肿瘤超过45 mm时实施。

主要发现

  • SDH突变在A组2例、B组11例中被发现。
  • 手术时间A组180 ± 77.3分钟,B组138 ± 54.5分钟,P=0.04。
  • 出血量B组203 ± 69.5 mL低于A组356 ± 102 mL,P=0.0001。
  • 接受术前辅助腔内操作者出血量149 ± 53 mL(n=15),低于直接手术者273 ± 88 mL(n=42),P=0.0001。
  • 7例出现单侧肿瘤复发,SDH突变者复发率显著高于野生型(P≤0.002);遗传评估发现7例新发无症状肿块(A组1例,B组6例,P=1.00)。

关键数值与推荐

  • 术前辅助腔内操作(颈外动脉支架、经股动脉栓塞或直接穿刺肿瘤同步栓塞)仅在B组肿瘤超过45 mm时实施。
  • 主要终点为出血量和颅神经损伤,次要终点为遗传评估后发现的新发无症状肿块数量。
  • 两组间短暂性与持续性颅神经损伤无差异;A组2例需颈动脉重建,B组0例,P=0.02。

临床怎么用

  • 对颈动脉体瘤患者建议采用多学科团队模式,整合遗传咨询、SDH基因检测、术前辅助腔内操作及术后康复。
  • 对肿瘤超过45 mm的选定病例可考虑术前辅助腔内操作以减少出血和颈动脉重建。
  • SDH突变患者术后应加强随访以监测复发和新发无症状肿块。

局限性

  • A组为回顾性评估,B组为前瞻性评估,存在方法学差异。
  • 术后康复项目的有效性尚需更大规模研究评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to evaluate how a multidisciplinary approach, including patients and familiar genetic counseling, preoperative succinate-dehydrogenase (SDH) gene mutation analysis, preoperative adjunctive endovascular procedures (PAEPs) and postoperative rehabilitative team may affect the outcomes in patients who underwent surgery for carotid body tumors (CBTs). METHODS: Fifty-seven consecutive CBT resections were performed from January 1995 to December 2019 in a single center institution. Two groups of patients were compared: group A (1995-2003; n = 10) and group B (2004-2019; n = 47), treated before and after the establishment of a multidisciplinary approach to CBTs. Group A and group B were evaluated retrospectively and prospectively for SDH mutations, respectively. PAEPs (external carotid artery stenting, percutaneous transfemoral embolization or direct percutaneous puncture of the tumor with simultaneous embolization) were performed only in patients of group B, when the size of the tumor exceeded the 45 mm. Primary endpoints were blood loss (BL) and cranial nerve injuries. Secondary endpoint was the number of new silent masses (NSMs) discovered after genetic evaluation. RESULTS: SDH mutations were found in 2 patients of group A and in 11 patients of group B. There were no significant differences in mass diameter between the groups. A significant difference regarding the surgical procedure time was observed in the 2 groups, with a higher time in the group A (Group A: 180 ± 77.3; Group B: 138 ± 54.5, P= 0.04). BL was significantly lower in group B (203 ± 69.5 mL vs. 356 ± 102 mL; P = 0.0001), as well as for patients underwent PAEPs vs. those underwent direct surgery (n = 15, 149 ± 53 mL vs. n = 42, 273 ± 88 mL; P = 0.0001). No differences between transient and persistent cranial nerve injuries were observed between the 2 groups. Carotid reconstruction was necessary for 2 patients of group A (n = 2 vs. n = 0; P = 0.02). Unilateral tumor recurrence was detected in 7 patients, with a significantly higher rate (P ≤ 0.002) in patients carrying SDH mutations compared to those without SDH mutation (wild-type). SDH mutations detected in the groups lead to discover 7 NSMs (group A n = 1 vs. group B n = 6; P = 1.00). CONCLUSION: The impact of the multidisciplinary team suggests that surgical resection still remains the gold standard for the treatment of CBTs, but the use of PAEPs in selected cases may reduce surgical procedure time, BL and the need for reconstructive carotid surgery. Genetic counseling and SDH gene analysis allow to diagnose NSMs in asymptomatic patients. Larger studies should be considered to evaluate the effectiveness of postoperative rehabilitative program.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Menegolo M, Xodo A, Bozza R, et al. Improving Outcomes in Carotid Body Tumors Treatment: The Impact of a Multidisciplinary Team Approach. Ann Vasc Surg. 2021. PMID: 33556521. doi:10.1016/j.avsg.2021.01.074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。